441 related articles for article (PubMed ID: 25638778)
21. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
22. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Lee AY; Droppelmann N; Panageas KS; Zhou Q; Ariyan CE; Brady MS; Chapman PB; Coit DG
Ann Surg Oncol; 2017 Apr; 24(4):939-946. PubMed ID: 27804026
[TBL] [Abstract][Full Text] [Related]
23. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients.
Lehto US; Ojanen M; Kellokumpu-Lehtinen P
Ann Oncol; 2005 May; 16(5):805-16. PubMed ID: 15817599
[TBL] [Abstract][Full Text] [Related]
24. [Follow-up after melanoma resection is more extensive than recommended in the practice guidelines, primarily for reassurance of the patient].
Mijnhout GS; Teule GJ; Hoekstra OS; Pijpers R; Borgstein PJ; Meijer S
Ned Tijdschr Geneeskd; 1999 May; 143(19):997-1001. PubMed ID: 10368721
[TBL] [Abstract][Full Text] [Related]
25. Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma.
Hay JL; Oliveria SA; Dusza SW; Phelan DL; Ostroff JS; Halpern AC
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1212-6. PubMed ID: 16775183
[TBL] [Abstract][Full Text] [Related]
26. [Impact of French consensus conference concerning the follow-up of patients surgically treated for stage I melanoma among French dermatologists and oncologists].
Bafounta ML; Beauchet A; Poisson-Salomon AS; Saiag P
Ann Dermatol Venereol; 1999 Nov; 126(11):795-800. PubMed ID: 10612855
[TBL] [Abstract][Full Text] [Related]
27. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma.
Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti GL; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Cecchi R; Bottoni U; Bonci A; Scalvenzi M; Giannotti B;
Arch Dermatol; 2003 May; 139(5):607-12. PubMed ID: 12756097
[TBL] [Abstract][Full Text] [Related]
28. Follow-up in patients with localised primary cutaneous melanoma.
Francken AB; Bastiaannet E; Hoekstra HJ
Lancet Oncol; 2005 Aug; 6(8):608-21. PubMed ID: 16054572
[TBL] [Abstract][Full Text] [Related]
29. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
[TBL] [Abstract][Full Text] [Related]
31. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
Uliasz A; Lebwohl M
Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of melanoma with regional lymph node metastases: a population-based study in France.
Lévy-Sitbon C; Barbe C; Granel-Brocard F; Lipsker D; Aubin F; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Le Clainche A; Dalle S; Bernard P; Grange F
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1081-7. PubMed ID: 22845015
[TBL] [Abstract][Full Text] [Related]
33. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia.
Watts CG; Madronio CM; Morton RL; Goumas C; Armstrong BK; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE
Australas J Dermatol; 2017 Nov; 58(4):278-285. PubMed ID: 27477217
[TBL] [Abstract][Full Text] [Related]
35. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
36. Skin-cancer screening: a three-year experience that paid for itself.
Limpert GH
J Fam Pract; 1995 May; 40(5):471-5. PubMed ID: 7730771
[TBL] [Abstract][Full Text] [Related]
37. S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version.
Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D;
J Dtsch Dermatol Ges; 2013 Jun; 11(6):563-602. PubMed ID: 23721604
[No Abstract] [Full Text] [Related]
38. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry.
Leiter U; Buettner PG; Eigentler TK; Bröcker EB; Voit C; Gollnick H; Marsch W; Wollina U; Meier F; Garbe C
J Am Acad Dermatol; 2012 Jan; 66(1):37-45. PubMed ID: 21700361
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
40. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
Turner RM; Bell KJ; Morton RL; Hayen A; Francken AB; Howard K; Armstrong B; Thompson JF; Irwig L
J Clin Oncol; 2011 Dec; 29(35):4641-6. PubMed ID: 22067399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
